American scientists have developed a new drug for the prevention of breast cancer. In addition, the vaccine is not only able to prevent the disease, but also to suspend the growth of a malignant tumor. The first trials on patients gave a positive result. It turned out that the vaccine not only reduces the intensity of tumor development, but also increases the duration and quality of life of patients.
Scientists intend to combine the resulting drug in combination with traditional cancer treatment drugs.
Available data show that the vaccine has no side effects and does not contribute to the occurrence of various complications in patients with cancer.